Safe New Therapy For Genetic Heart Disease

A new clinical trial suggests that long-term use of candesartan, a drug currently used to treat hypertension, may significantly reduce the symptoms of genetic heart disease. The related report by Penicka et al, “The effects of candesartan on left ventricular hypertrophy and function in non-obstructive hypertrophic cardiomyopathy: a pilot, randomized study,” appears in the January issue of The Journal of Molecular Diagnostics.

More: continued here

Filed under: Genetics on January 4th, 2009